and optimize models. Apply general software development skills in C# to integrate machine learning solutions within the broader..., and Keras. Solid experience in general software development using C#. Demonstrated expertise in deploying machine learning...
, we are seeking the best and brightest to join our team and help us execute our ambitious plans. What you’ll do As a Senior C...++ Developer with cross-platform and WebAssembly expertise you will: Design, develop, and maintain high-performance C++ software...
infrastructural part of Linux/C++ SDK - Refactor, maintain, and optimize the advanced Makefile-based build mechanism. Support... for cross-compilation, different compilers, and different Linux environments. - Work on refactoring and redesigning the C...
, production-grade cloud-based ERP, CRM, and other web applications using Microsoft technologies (.NET, C#, MS SQL Server.... You: You have 5+ years of experience in building commercial business applications using Microsoft technologies (.Net, C# and MS-SQL...
-scale, production-grade cloud-based ERP, CRM, and other web applications using Microsoft technologies (.NET, C#, MS SQL... technologies (.Net, C# and MS-SQL) You have strong knowledge of C# and experience in writing, profiling and optimization...
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »
Anand Rathi recommends 2 'emerging picks' for July 2024, focusing on CONCOR and ideaForge Technology with a time horizon of 30-90 days. Continue Reading »
Stock Market Today: Sun Pharma share price has risen almost 25% year to date. The news flow recently has remained around regulatory actions by the USFDA for Dadra nd Halol plant Should you Buy , Sell or Hold the stock? Continue Reading »
Bansal Wire IPO subscription status shows overwhelming response from investors, with 59.57 times subscription. QIBs, NIIs, and retail investors actively participated. Price band set at ₹243-256 per share. Analysts bullish on long-term prospects, expecting decent listing gains of over 25%. Continue Reading »
V-Mart acquired Limeroad in FY23 to push its omnichannel strategy, but has been cutting costs to reduce Limeroad’s losses of late..Limeroad’s Ebitda loss in FY24 stood at ₹71.6 crore and V-Mart expects the FY25 loss to be 40-50% of that. Continue Reading »